AGIOS PHARMACEUTICALS, INC. Insider Trading for September 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for September 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 35,000 | 10,588 | 118,656 | |
| Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 67.12 | 35,000 | 2,349,200 | 0 | 35 K to 0 (-100.00 %) |
| Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 35,000 | 10,588 | 35,000 | 0 to 35 K |
| Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Gift | G | 0.00 | 500 | 0 | 271,772 | 272.3 K to 271.8 K (-0.18 %) |
| Sep 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 65.71 | 1,000 | 65,710 | 85,434 | 86.4 K to 85.4 K (-1.16 %) |
| Sep 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 65.71 | 1,000 | 65,710 | 85,394 | 86.4 K to 85.4 K (-1.16 %) |
| Sep 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 65.47 | 1,000 | 65,470 | 86,434 | 87.4 K to 86.4 K (-1.14 %) |
| Sep 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 65.47 | 1,000 | 65,470 | 86,394 | 87.4 K to 86.4 K (-1.14 %) |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 6,000 | 210,960 | 109,000 | |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 65.00 | 6,000 | 390,000 | 881 | 6.9 K to 881 (-87.20 %) |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 6,000 | 210,960 | 6,881 | 881 to 6.9 K (+681.04 %) |
| Sep 13 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 65.00 | 15,000 | 975,000 | 10,470 | 25.5 K to 10.5 K (-58.89 %) |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 2,146 | 19,421 | 35,281 | |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 61.99 | 2,146 | 133,031 | 6,264 | 8.4 K to 6.3 K (-25.52 %) |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 2,146 | 19,421 | 8,410 | 6.3 K to 8.4 K (+34.26 %) |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 153,656 | |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 62.20 | 6,000 | 373,200 | 0 | 6 K to 0 (-100.00 %) |
| Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |